AAC Holdings, Inc. provides inpatient and outpatient substance use treatment services for individuals with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues in the United States. Its therapy services include motivational interviewing, cognitive behavioral therapy, rational emotive behavior therapy, dialectical behavioral therapy, solution-focused therapy, eye movement desensitization and reprocessing, and systematic family intervention. As of June 30, 2018, the company operated 11 inpatient substance abuse treatment facilities, focused on delivering clinical care and treatment solutions across 1,112 inpatient beds, including 732 licensed detoxification beds, 26 standalone outpatient centers, and 5 sober living facilities across 409 beds for a total of 1,521 combined inpatient and sober living beds. It also offers Internet marketing services to families and individuals struggling with addiction and seeking treatment options through online directories of treatment providers, treatment provider reviews, forums, and professional communities; and online marketing solutions to other treatment providers, such as facility profiles, audience targeting, lead generation, and tools for digital reputation management. In addition, the company performs drug testing and diagnostic laboratory services; and provides physician services to its clients. AAC Holdings, Inc. was founded in 2014 and is headquartered in Brentwood, Tennessee.
Industry, Sector and Symbol
Industry Specialty outpatient clinics, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Phone615-732-1231
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$317.64 million
Profitability
Miscellaneous
Employees2,100
OptionableOptionable
AAC (NYSE:AAC) Frequently Asked Questions
What is AAC's stock symbol?
AAC trades on the New York Stock Exchange (NYSE) under the ticker symbol "AAC."
How were AAC's earnings last quarter?
AAC Holdings Inc (NYSE:AAC) released its quarterly earnings data on Tuesday, November, 6th. The company reported ($0.08) EPS for the quarter, missing the Zacks' consensus estimate of $0.24 by $0.32. The company had revenue of $77.47 million for the quarter, compared to the consensus estimate of $84.21 million. AAC had a positive return on equity of 4.21% and a negative net margin of 10.20%. The company's revenue for the quarter was down 3.7% compared to the same quarter last year. During the same period last year, the firm earned $0.12 earnings per share. View AAC's Earnings History.
When is AAC's next earnings date?
What guidance has AAC issued on next quarter's earnings?
AAC updated its FY 2018 earnings guidance on Tuesday, November, 6th. The company provided EPS guidance of $-0.15--0.1 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.72. The company issued revenue guidance of $315-320 million, compared to the consensus revenue estimate of $337.24 million.AAC also updated its FY18 guidance to ($0.15-0.10) EPS.
What price target have analysts set for AAC?
2 analysts have issued twelve-month price targets for AAC's stock. Their predictions range from $4.00 to $12.00. On average, they expect AAC's stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 200.8% from the stock's current price. View Analyst Price Targets for AAC.
What is the consensus analysts' recommendation for AAC?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AAC in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for AAC.
What are Wall Street analysts saying about AAC stock?
Here are some recent quotes from research analysts about AAC stock:
- 1. According to Zacks Investment Research, "AAC Holdings, Inc. is a provider of inpatient substance abuse treatment services for individuals with drug and alcohol addiction. It provides detoxification, residential treatment, partial hospitalization, and intensive outpatient care services. AAC Holdings, Inc. is headquartered in Brentwood, Tennessee. " (1/8/2019)
- 2. Cantor Fitzgerald analysts commented, "1Q18 results were ahead of consensus on both the top and bottom lines, although consensus is comprised of only three estimates. Results were boosted by the AdCare acquisition (closed March 1), but we expect more earnings impact from AdCare in 2Q18 and beyond." (5/2/2018)
Has AAC been receiving favorable news coverage?
Media stories about AAC stock have trended somewhat positive on Thursday, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. AAC earned a news sentiment score of 1.2 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days.
Who are some of AAC's key competitors?
Some companies that are related to AAC include Urovant Sciences (UROV), Vapotherm (VAPO), Kadmon (KDMN), Neuronetics (STIM), Intec Pharma (NTEC), Verrica Pharmaceuticals (VRCA), Savara (SVRA), Catalyst Pharmaceuticals (CPRX), Nuvectra (NVTR), Genesis Healthcare (GEN), RTI Surgical (RTIX), Taxus Pharmaceuticals (TXSP), Translate Bio (TBIO), Marker Therapeutics (MRKR) and Gamida Cell (GMDA).
Who are AAC's key executives?
AAC's management team includes the folowing people:
- Mr. Michael T. Cartwright, Chairman & CEO (Age 51)
- Dr. Thomas W. Doub, Chief Compliance Officer & Chief Clinical Officer (Age 50)
- Mr. Michael Nanko Ph.D., Pres & COO (Age 63)
- Mr. Andrew W. McWilliams, CFO & Chief Accounting Officer (Age 47)
- Mr. Michael J. Stetar, Chief Technology Officer
How do I buy shares of AAC?
Shares of AAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is AAC's stock price today?
One share of AAC stock can currently be purchased for approximately $2.66.
How big of a company is AAC?
AAC has a market capitalization of $69.13 million and generates $317.64 million in revenue each year. The company earns $-20,570,000.00 in net income (profit) each year or $0.60 on an earnings per share basis. AAC employs 2,100 workers across the globe.
What is AAC's official website?
How can I contact AAC?
AAC's mailing address is 200 POWELL PLACE, BRENTWOOD TN, 37027. The company can be reached via phone at 615-732-1231 or via email at [email protected]
MarketBeat Community Rating for AAC (NYSE AAC)
MarketBeat's community ratings are surveys of what our community members think about AAC and other stocks. Vote "Outperform" if you believe AAC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AAC will underperform the S&P 500 over the long term. You may vote once every thirty days.
